Innovative research focusing on COPD and severe asthma management, evaluating new therapeutic approaches for patients with exacerbations. Studies aim to assess novel treatments and predict treatment responses. Research includes evaluation of treatments like tozorakimab and benralizumab for improved patient outcomes. Comprehensive studies in lung cancer and neuroendocrine tumors , exploring innovative immunotherapy approaches and targeted treatments for various cancer types.
Trials focus on durvalumab combinations and novel targeted therapies for advanced stages of cancer. Studies include novel drug delivery methods and stem cell treatments for various neurological conditions. Investigating treatments for atrial arrhythmias and complex cardiac conditions, with focus on anticoagulation strategies and ventricular function improvement. This clinical trial is focused on studying a type of lung cancer known as Small Cell Lung Cancer SCLC , specifically in patients whose disease is limited to the chest area.
The study is investigating the use of a treatment called durvalumab, also known by its code name MEDI Durvalumab is a type of immunotherapy, whichβ¦. This clinical trial is focused on studying the effectiveness of two treatments for managing gout flare-ups in patients who have chronic kidney disease at stages 3b, 4, or 5, or who have undergone a kidney transplant. The trial involves two medications: anakinra, which is given as an injection, and prednisone, which is taken as aβ¦.
This clinical trial is focused on studying a type of cancer called locally advanced anal squamous cell carcinoma. This is a cancer that affects the anal area and has grown to a more advanced stage but has not spread to other parts of the body. The study is comparing two different treatment approaches to seeβ¦. This clinical trial is focused on studying a type of blood cancer called multiple myeloma, which affects the plasma cells in the bone marrow.
The study is investigating the effectiveness of a combination of medications: Daratumumab, Lenalidomide, and Dexamethasone. Daratumumab, also known by its code name HuMax-CD38, is a protein-based treatment given through an injection. This clinical trial is focused on studying a type of lung cancer known as non-small-cell lung cancer NSCLC that has a specific change in its genes called ROS1 gene rearrangement.
